Sublingual immunotherapy in mite-sensitized patientswith atopic dermatitis: a randomized controlled study

医学 狭缝 斯科拉德 特应性皮炎 屋尘螨 随机对照试验 不利影响 免疫球蛋白E 可视模拟标度 螨 内科学 敏化 舌下免疫疗法 治疗效果 皮肤病科 免疫疗法 外科 免疫学 抗体 疾病 皮肤科生活质量指数 植物 遗传学 癌症 生物
作者
Nan-sheng Yu,Hongyu Luo,Donglong Liang,Na Lü
出处
期刊:Postepy Dermatologii I Alergologii [Termedia Publishing House]
卷期号:38 (1): 69-74 被引量:11
标识
DOI:10.5114/ada.2021.104281
摘要

Introduction: Sublingual immunotherapy (SLIT) has been shown to be efficacious in patients with airway allergic diseases. However, less data have been demonstrated to show the efficacy of SLIT in patients with atopic dermatitis (AD). Aim: This study is to evaluate, in a randomized controlled study, the effect of SLIT with house dust mite (HDM) in patients with mild-moderate AD. Material and methods: AD patients aged 4 to 60 years with a Scoring Atopic Dermatitis (SCORAD) score of 7-40 and sensitization to HDM were enrolled in the study. SLIT or control treatment was given for 24 months. SCORAD, visual analog scale (VAS) score were recorded at 6, 12, 24 month, and rescue medications were required to be recorded in the diary card. A serum level of specific IgE was tested at 24-month treatment. Results: Ninety-six patients were enrolled, and forty-eight were allocated to SLIT. Thirty-nine patients in the SLIT group and thirty-eight patients in the control group completed the study. The patients in the SLIT group had significantly decreased SCORAD, VAS and rescue medication score from 12 months' treatment compared with the control group (p < 0.05). At 24 months of treatment, no significant change of specific IgE (p < 0.05) was observed in both groups. No severe adverse events were reported during the treatment. Conclusions: Two years' SLIT to HDM significantly improved the clinical symptoms and reduced drug use in patients with mild-moderate AD. SLIT may represent an additional therapeutic tool for the treatment of AD in properly selected patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
王梦瑶完成签到 ,获得积分10
刚刚
1秒前
谢尔顿发布了新的文献求助10
1秒前
林林关注了科研通微信公众号
1秒前
FashionBoy的应助被苑小胖采纳,获得10
1秒前
1秒前
高大抽屉完成签到,获得积分10
2秒前
2秒前
3秒前
馒头发布了新的文献求助10
3秒前
17826539164关注了科研通微信公众号
4秒前
4秒前
无极微光的应助被科研通管家采纳,获得20
5秒前
Jun的应助被科研通管家采纳,获得10
5秒前
SciGPT的应助被科研通管家采纳,获得10
5秒前
Jun的应助被科研通管家采纳,获得10
5秒前
天天快乐的应助被科研通管家采纳,获得10
5秒前
Jasper的应助被科研通管家采纳,获得10
5秒前
传奇3的应助被科研通管家采纳,获得10
5秒前
秋风的应助被科研通管家采纳,获得20
5秒前
6秒前
Owen的应助被科研通管家采纳,获得10
6秒前
初景的应助被科研通管家采纳,获得20
6秒前
李爱国的应助被科研通管家采纳,获得10
6秒前
原味薯片完成签到,获得积分10
6秒前
深情安青的应助被科研通管家采纳,获得10
6秒前
余香的应助被科研通管家采纳,获得10
6秒前
秋风的应助被科研通管家采纳,获得20
6秒前
小二郎的应助被科研通管家采纳,获得10
7秒前
在水一方的应助被科研通管家采纳,获得10
7秒前
7秒前
传奇3的应助被科研通管家采纳,获得10
7秒前
大河同志发布了新的文献求助10
7秒前
7秒前
7秒前
君无双的应助被科研通管家采纳,获得10
7秒前
爆米花的应助被科研通管家采纳,获得10
7秒前
思源的应助被科研通管家采纳,获得10
7秒前
7秒前
酷波er的应助被科研通管家采纳,获得10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187612
求助须知:如何正确求助?哪些是违规求助? 9575734
关于积分的说明 21842594
捐赠科研通 7785476
什么是DOI,文献DOI怎么找? 3435073
关于科研通互助平台的介绍 2559478
邀请新用户注册赠送积分活动 2481952